Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Bullboard - Stock Discussion Forum Hillevax Inc HLVX

HilleVax, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing vaccines. The Company's programs, HIL-214 and HIL-216, are virus-like particle (VLP) based vaccine candidates in development for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. HIL-214 consists of VLPs which are designed to mimic the structure of... see more

Bullboard (NDAQ:HLVX)

View:
User Avatar Image
(10)
•••
  • MikeTesterX
Post by MikeTesteron Jan 24, 2025 8:59pm

HilleVax (HLVX): Navigating the Evolving Norovirus Vaccine L

Tough break for HLVX. Phase 2b trial for HIL-214 totally missed the mark with only 5% efficacy in infants. Stock's gonna get hammered. Management's doing damage control with 40% workforce ...more  
Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}

At the Bell logo
A daily snapshot of everything
from market open to close.

Podcasts